TNF Receptors in Chronic Lymphocytic Leukemia

References

• Hohmann H.P., Remy R., Brockhaus M., van Loon A. P. G. M. Two different cell types have different major receptors for human tumor necrosis factor (TNFα). J. Biol. Chem. 1989; 264: 14927–14934
   PubMed Web of Science ®Google Scholar
• Banner D.W., D'arcy A., Janes W., Gentz R., Schoen-Feld H.-J., Broger C., Loetscher H., Lesslauer W. Crystal structure of the soluble human 55 kd TNF-receptor-human TNFbeta complex: implications for TNF activation. Cell 1993; 73: 431–445
   PubMed Web of Science ®Google Scholar
• Lewis M., Tartaglia L.A., Lee A., Bennett G.L., Rice G.C., Wong G. H. W., Chen E.Y., Goeddel D.V. Cloning and expression of cDNA for two distinct mu-rine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 1991; 88: 2830–2834
   PubMed Web of Science ®Google Scholar
• Espevik T., Brockhaus M., Loetscher H., Nonstad U., Shalaby R. Characterization of binding and biological effects of monoclonal antibodies against a human tumor ne crosis factor receptor. J. Exp. Med. 1990; 171: 415–426
   PubMed Web of Science ®Google Scholar
• Tartaglia L.A., Goeddel D.V. Two TNF re ceptors. Immunol. Today 1992; 13: 151–153
   PubMedGoogle Scholar
• Shalaby M.R., Sundan A., Loetscher H., Brockhaus M., Lesslauer W., Espevik T. Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. J. Exp. Med. 1990; 172: 1517–1520
   PubMed Web of Science ®Google Scholar
• Lantz M., Gullberg U., Nilsson E., Olsson I. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. J. Clin. Invest. 1990; 86: 1396–1402
   PubMed Web of Science ®Google Scholar
• Naume B., Johnsen A.-C., Espevik T., Sundan A. Gene expression and secretion of cytokines and cy-tokine receptors from highly purified CD56+ NK cells stim ulated with IL-2, IL-7 and IL-12. Eur. J. Immunol. 1993, in press
   PubMed Web of Science ®Google Scholar
• Porteu F., Brockhaus M., Wallach D., Engelmann H., Nathan C.F. Human neutrophil elastase releases a ligand-binding fragment from the 75.-kDa tumor necrosis fac tor (TNF) receptor. J. Biol. Chem. 1991; 266: 18846–18853
   PubMed Web of Science ®Google Scholar
• Liabakk N.-B., Sundan A., Lien E., Lægreid A., Bom-Bara M.P., Ranges G., Espevik T. The release of p55 TNF receptor from U937 cells studied by a new p55 immunoassay. J. Immunol. Methods 1993, in press
   PubMed Web of Science ®Google Scholar
• Liabakk N.-B., Sundan A., Waage A., Brockhaus M., Loetscher H., Lesslauer W., Espevik T. Devel opment of immunoassays for the detection of soluble turnour necrosis factor receptors. J. Immunol. Methods 1991; 141: 237–243
   PubMed Web of Science ®Google Scholar
• Waage A., Liabakk N., Lien E., Lamvik J., Espevik T. p55 and p75 tumor necrosis factor receptors in pa tients with chronic lymphocytic leukemia. Blood 1992; 80: 2577–2583
   PubMed Web of Science ®Google Scholar
• Aderka D., Engelmann H., Wallach D. Soluble tumor necrosis factor receptors in health and disease. Tumor necrosis factor: molecular and cellular biology and clinical relevance, W. Fiers, W.A. Buurman. S. Karger AG, Basel 1993; 191–198
   Google Scholar
• Aderka D., Engelmann H., Homik V., Skomick Y., Levo Y., Wallach D., Kushtai G. Increased serum lev els of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res. 1991; 51: 5602–5607
   PubMed Web of Science ®Google Scholar
• Van Zee K.J., Kohno T., Fischer E., Rock C.S., Mol-Dawer L.L., Lowry S.F. Tumor necrosis factor soluble receptors circulate during experimental and clinical in flammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc. Natl. Acad. Sci. USA 1992; 89: 4845–4849
   PubMed Web of Science ®Google Scholar
• Kehrl J.H., Miller A., Fauci A.S. Effect of tumor necrosis factor α on mitogen-activated human B cells. J. Exp. Med. 1987; 166: 786–791
   PubMed Web of Science ®Google Scholar
• Sung S.-S. J., Jung L. K. L., Walters J.A., Chen W., Wang C.Y., Fu S.M. Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J. Exp. Med. 1988; 168: 1539–1551
   PubMed Web of Science ®Google Scholar
• Smeland E., Kiil Blomhoff H., Funderud S., Shalaby M.R., Espevik T. Interleukin 4 induces selective pro duction of interleukin 6 from normal human B lymphocytes. J. Exp. Med. 1989; 170: 1463–1468
   PubMed Web of Science ®Google Scholar
• Sung S.-S. J., Bjorndahl J.M., Wang C.Y., Kao H.T., Fu S.M. Production of tumor necrosis factor/ cachectin by human T cell lines and peripheral blood T lym phocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J. Exp. Med. 1988; 167: 937–953
   PubMed Web of Science ®Google Scholar
• Erikstein B.K., Smeland E.B., Kiil Blomhoff H., Fun derud S., Lesslauer E., Espevik T. Increased expression of tumor necrosis factor receptors during activation of human B lymphocytes; independent regulation of 55 kD and 75 kD TNF receptors. Eur. J. Immunol. 1991; 21: 1033–1037
   PubMed Web of Science ®Google Scholar
• Heilig B., Mapara M., Brockhaus M., Krauth K., Dorken B. Two types of TNF receptors are expressed on human normal and malignant B lymphocytes. Clin. Immunol. Immunopathol 1991; 61: 260–267
   PubMedGoogle Scholar
• Cordingly F.T., Bianchi A., Hoffbrand A.V., Reittie J.E., Heslop H.E., Vyakarnam A., Tumer M., Meager A. Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancer 1988; i: 969–971
   Google Scholar
• Digel W., Stefanic M., Schöniger W., Buck C., Raghav-Achar A., Frickhofen N., Heimpel H., Prozsolt F. Tumor necrosis factor induces ptoliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood 1989; 73: 1242–1246
   PubMed Web of Science ®Google Scholar
• Foa R., Massaia M., Cardona S., Tos A.G., Bianchi A., Attisano C., Fuarini A., di Celle P.F., Fierro M.T. Production of tumor necrosis factor-α by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease. Blood 1990; 76: 393–400
   PubMed Web of Science ®Google Scholar
• Heslop H.E., Bianchi A. C. M., Cordingley F.T., Turner M., De Mel W. C. P., Hoffbrand A.V., Brenner M.K. Effects of interferon α on autocrine growth factor loops in B lymphoproliferative disorders. J. Exp. Med. 1990; 172: 1729–1734
   PubMed Web of Science ®Google Scholar
• Van Kooten C., Rensink I., Aarden L., van Oeris R. Interleukin-4 inhibits both paracrine and autocrine tumor necrosis factor-α-induced proliferation of B chronic lym-phocytic leukemia cells. Blood 1992; 80: 1299–1306
   PubMed Web of Science ®Google Scholar
• Hahn T., Kusminsky G., Bassous L., Barak Y., Ber-Rebi A. Tumour necrosis factor in B chronic lympho-cytic leukaemia. Br. J. Haematol. 1989; 71: 299–304
   PubMed Web of Science ®Google Scholar
• Zambello R., Trentin L., Bulian P., Cassatella M., Rai-Mondi R., Chisesi T., Agostini C., Semenzato G. Role of tumor necrosis factor-α and its specific 55-Kd and 75-Kd receptors in patients with lymphoproliferative disease of granular lymphocytes. Blood 1992; 80: 2030–2037
   PubMed Web of Science ®Google Scholar
• Engelberts I., Stephens S., Francot G. J. M., van der Lin den C.J., Buurrnan W.A. Evidence for different effects of soluble TNF-receptors on various TNF measure ments in human biological fluids. Lancet 1991; 338: 515–516
   PubMed Web of Science ®Google Scholar
• Digel W., Schöniger W., Stefanic M., Janssen H., Buck C., Schmid M., Raghavachar A., Porzsolt F. Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo. Blood 1990; 76: 1607–1613
   PubMed Web of Science ®Google Scholar
• Trentin L., Zambello R., Agostini C., Siviero F., Adarni F., Marcolongo R., Raimondi R., Chisesi T., Pizzolo G., Sernenzato G. Expression and functional role of tumor necrosis factor receptors of leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood 1993; 81: 752–758
   PubMed Web of Science ®Google Scholar
• Ryffel B., Brockhaus M., Durmuller U., Gudat F. Tumor necrosis factor receptors in lymphoid tissues and lym-phomas. Am. J. Pathol. 1991; 139: 7–15
   PubMed Web of Science ®Google Scholar
• Digel W., Porzsolt F., Schmid M., Henmann F., Les-Slauer W., Brockhaus M. High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia. J. Ctin. Invest. 1992; 89: 1690–1693
   PubMed Web of Science ®Google Scholar
• Aderka D., Engelmann H., Maor Y., Brakebusch C., Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 1992; 175: 323–329
   PubMed Web of Science ®Google Scholar